klow group (GHK-CU, TB-500, BPC-157, KPV) KLOW - Exploring Peptides

Neuroprotective potential Researchers have opened unprecedented avenues by combining GHRP-6 with Epidermal Growth Factor (EGF) as a therapeutic approach for neurological conditions

Glutathione recycling is a slow, cumulative process, not a one-off event

Shortening the fatty acid chain length of rat ghrelin was reported to gradually increase the EC 50 (half maximal effective concentration) for receptor activation by 10-fold with hexanoyl (C6:0), 200-fold with butyryl (C4:0), and 500-fold with acetyl (C2:0) (Matsumoto et al., 2001)

We offer cutting-edge glutathione treatments to address several conditions associated with glutathione deficiency